Liposomal Doxorubicin Market to Reach USD 2.15 Billion by 2033 - Strategic Revenue Insights (SRI)
Global market grows at 6.3% CAGR through 2033 as demand rises for safer, targeted chemotherapy treatments worldwide. LONDON, UNITED KINGDOM, UNITED KINGDOM, February 6, 2026 /EINPresswire.com/ -- London, United Kingdom, February 05, 2026 – …